BioSig Technologies Announces First Clinical Cases with PURE EP System: Interview with Ken Londoner, CEO

May 9, 2019

Ken Londoner interviewed by Christine Corrado for Proactive Investors

December 11, 2018

Ken Londoner interviewed by Ray Hoffman for CEO Radio-WCBS

August 21, 2018

BioSig (BSGM) Looking Undervalued with Disruptive Technology in $4B EP Market

July 18, 2018

BioSig Technologies Inc. (OTCQB: BSGM)

April 24, 2017